Inhalationsprodukte

Inhalationsprodukte are devices or substances used to deliver medication or therapeutic agents directly into the lungs through inhalation. These products are commonly prescribed for respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, as well as for the treatment of severe viral infections like influenza and COVID-19.

The primary mechanism of action for inhalationsprodukte involves converting a liquid medication into an aerosol, a fine mist of droplets that can be inhaled deep into the airways. This method allows for rapid absorption of the drug into the lung tissue, providing targeted relief and minimizing systemic side effects compared to oral medications.

Common types of inhalationsprodukte include metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers. MDIs deliver a specific dose of medication with each actuation, typically propelled by a propellant. DPIs utilize the user's breath to draw the medication powder into the lungs. Nebulizers are electronic devices that convert liquid medication into a fine mist over a longer period, making them suitable for patients who have difficulty using inhalers or for delivering larger doses.

The development and use of inhalationsprodukte are crucial for managing chronic respiratory diseases, improving lung function, and enhancing the quality of life for affected individuals. Proper training on the correct usage of these devices is essential to ensure optimal therapeutic benefit and patient adherence.